Stejskal Pavel MSc

Circulating tumor cells detection

Circulating tumor cells detection and analysis using direct detection method in patients with glioblastoma multiforme

Pavel Stejskal, MSc is involved in the research that aims to understand the additional value of liquid biopsy as a clinically relevant diagnostic, prognostic and predictive tool. His research is focused on the development of experimental models to explain the biology underlying the release of circulating tumor-related materials into blood. He also focuses on the implementation of complex genomic analyses by liquid biopsy-based biomarkers (circulating tumor cells, circulating tumor DNA, extracellular vesicles, free circulating biomarkers) in the diagnosis, follow-up and therapy of cancer patients.